American Journal of Cardiology
Volume 97, Issue 6 , Pages 768-771, 15 March 2006

Detection of Myocardial Scar by Contrast-Enhanced Cardiac Magnetic Resonance Imaging in Patients With Troponin-Positive Chest Pain and Minimal Angiographic Coronary Artery Disease

  • Jonathan P. Christiansen, MB, ChB, MD

      Affiliations

    • Cardiovascular Division, North Shore Hospital, Waitemata Health, Auckland, New Zealand
    • Corresponding Author InformationCorresponding author: Tel: 64-9-486-1491; fax: 64-9-486-8963.
  • ,
  • Colin Edwards, MB, BCh

      Affiliations

    • Cardiovascular Division, North Shore Hospital, Waitemata Health, Auckland, New Zealand
  • ,
  • Toni Sinclair, BHSc

      Affiliations

    • Radiology Group, Auckland, New Zealand
  • ,
  • Guy Armstrong, MB, ChB

      Affiliations

    • Cardiovascular Division, North Shore Hospital, Waitemata Health, Auckland, New Zealand
  • ,
  • Anthony Scott, MB, ChB

      Affiliations

    • Cardiovascular Division, North Shore Hospital, Waitemata Health, Auckland, New Zealand
  • ,
  • Hitesh Patel, MB, ChB

      Affiliations

    • Cardiovascular Division, North Shore Hospital, Waitemata Health, Auckland, New Zealand
  • ,
  • Hamish Hart, MB, BCh

      Affiliations

    • Cardiovascular Division, North Shore Hospital, Waitemata Health, Auckland, New Zealand

Received 18 August 2005; received in revised form 3 October 2005; accepted 3 October 2005. published online 20 January 2006.

Patients who present with chest pain and elevated serum troponin levels may have minimal angiographic coronary artery disease, leading to diagnostic confusion. We investigated patients with troponin-positive acute coronary syndromes and minimal coronary artery disease (CAD) using contrast-enhanced cardiac magnetic resonance imaging to assess for myocardial scar. Twenty-three patients (54 ± 8 years of age) who presented with chest pain, high troponin I level, and minimal angiographic CAD were included. Patients with a clinical pericarditis/myocarditis, tachyarrhythmia at presentation, previous myocardial infarction, or an alternative explanation for increased troponin I level were excluded. Myocardial scar was assessed with delayed-enhancement inversion-recovery imaging after administration of gadolinium. Hyperenhancement consistent with myocardial scar was seen in 7 of 23 patients (30%) and was located primarily in the right coronary artery distribution. Peak troponin level, clinical characteristics, and volumetric parameters were similar in patients with or without hyperenhancement. One patient had mid-myocardial enhancement that suggested undiagnosed myocarditis. There was a linear relation between the mass of myocardial scar and peak serum troponin level. In follow-up, subsequent cardiac events were more frequent in patients with hyperenhancement (43% vs 12.5%). In conclusion, patients with troponin-positive acute coronary syndromes may have significant myocardial scar even when minimal CAD is found on angiography.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0002-9149(05)02061-8

doi:10.1016/j.amjcard.2005.10.016

American Journal of Cardiology
Volume 97, Issue 6 , Pages 768-771, 15 March 2006